EducationRegionalUttar pradesh

Substantial increase in jobs in the medical sector; Demand for Pharmacy courses go up

Credit: Google

The increase in the number of admissions in pharmacy courses across the state, for degree and diploma courses, have gone up by nearly 25 percent in the academic year 2020-21 as compared to 2019-20, as the number of students enrolled in B Pharma courses have gone up from 16,000 to over 20,000.

Due to the high salary packages and the growth of the medical sector, even amid the prevailing Covid-19 pandemic, the interest of students in B Pharm and D Pharm courses has increased. In addition, there has been almost 100 percent enrollment in D Pharm courses in the academic session 2020-21.

In the last two years, there has been a rapid rise in the number of B. Pharma institutions as well as students in the state. According to the AKTU spokesperson Ashish Mishra, in the last one and a half years, more than 50 B Pharma institutes have been affiliated to AKTU. Among them, the number of students has also increased.

According to Mishra, after completing B Pharma and D Pharma courses, one can provide services by becoming a consultant with any pharmaceutical company or be a hospital pharmacist or work as a clinical research associate. Apart from this, one can also start their own medical firm.

Almost 100 percent enrollment in D Pharma courses

There are a total 57,568 seats of D Pharma course in the state. According to the Department of Technical Education, admissions on as many as 56,291 seats were done in the session 2020-21. At the same time, as many as 20,361 students took admission in 25,351 seats available for the B Pharma course.

Admission to be done under NTA in B Pharma

At present, the fourth stage of the process of admission to engineering seats through JEE is going on. In the current session, the admission in B Pharm course will be done through the National Testing Agency. After the completion of the process of admission to B Tech, the admission procedure to the B Pharma course will start.

Pranchal Srivastava